MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 12-16-2024
Enzo Biochem Total Inventories 2011-2026 | ENZ
Annual Total Inventories Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.83 M | 7.94 M | 9.52 M | 12.7 M | 7.78 M | 7.84 M | 7.28 M | 7.05 M | 6.97 M | 7.4 M | 8.69 M | 8.8 M | 8.8 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.7 M | 6.83 M | 8.27 M |
Quarterly Total Inventories Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.39 M | 6.83 M | 7.32 M | 7.8 M | 7.6 M | 7.94 M | 15.3 M | 13.9 M | 15.8 M | 15.4 M | 14.9 M | 9.26 M | 14 M | 12.7 M | 12.7 M | 7.5 M | 8.18 M | 7.78 M | 7.78 M | 7.51 M | 7.57 M | 7.84 M | 7.6 M | 7.48 M | 7.59 M | 7.28 M | 7.28 M | 7.12 M | 7.21 M | 7.05 M | 7.05 M | 7.4 M | 7.25 M | 6.97 M | 6.97 M | 8.28 M | 7.58 M | 7.4 M | 7.4 M | 9.22 M | 8.52 M | 8.69 M | 8.69 M | 9.3 M | 9.11 M | 8.8 M | 8.8 M | 9.39 M | 8.67 M | 8.8 M | 8.8 M | - | 9.22 M | 9.26 M | 9.26 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.8 M | 6.39 M | 8.91 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
123 M | $ 23.0 | 2.86 % | $ 248 M |  China |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
13.3 M | $ 1.6 | -0.22 % | $ 2.03 M | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.66 M | $ 6.1 | 1.16 % | $ 179 M | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 39.93 | -1.67 % | $ 1.11 B | USA |
 |
Danaher Corporation
DHR
|
2.33 B | $ 234.99 | -0.25 % | $ 172 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | China |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
5.06 M | $ 12.98 | 6.97 % | $ 368 M |  Israel |
 |
DexCom
DXCM
|
560 M | $ 68.47 | -2.33 % | $ 26.4 B | USA |
 |
CareDx, Inc
CDNA
|
19.5 M | $ 17.5 | -7.41 % | $ 941 M | USA |
 |
Exact Sciences Corporation
EXAS
|
162 M | $ 101.77 | 0.14 % | $ 18.9 B | USA |
 |
Guardant Health
GH
|
71.1 M | $ 107.75 | -1.98 % | $ 13.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
279 M | $ 48.19 | 1.71 % | $ 10.7 B |  Niderland |
 |
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
547 M | $ 146.41 | -2.48 % | $ 23.3 B | USA |
 |
Charles River Laboratories International
CRL
|
279 M | $ 214.0 | -1.51 % | $ 11 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
188 M | $ 177.06 | -0.64 % | $ 19.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
493 M | $ 254.76 | 0.43 % | $ 21.4 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 189.39 | -6.67 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
382 M | $ 708.9 | -0.79 % | $ 58.5 B | USA |
 |
Lantheus Holdings
LNTH
|
68 M | $ 68.27 | -1.59 % | $ 4.72 B | USA |
 |
Agilent Technologies
A
|
830 M | $ 145.56 | -1.51 % | $ 44.3 B | USA |
 |
Biomerica
BMRA
|
1.49 M | $ 2.83 | 1.8 % | $ 6.5 M | USA |
 |
Bioventus
BVS
|
91.3 M | $ 8.0 | 5.12 % | $ 501 M | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
384 K | $ 23.85 | 2.49 % | $ 31 M | USA |
 |
Mettler-Toledo International
MTD
|
342 M | $ 1 461.94 | -0.56 % | $ 31 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
27.5 M | $ 6.63 | -0.08 % | $ 601 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.62 M | $ 4.64 | 1.75 % | $ 2.49 M | USA |